{
  "docId": "019de074-1317-767b-825b-77b5f795fc6c",
  "docSlug": "27adacda91e6c92061c4de59bd9e9dc9",
  "documentTitle": "Theravance Biopharma | Investor Conference Presentation Deck | 44 slides",
  "authorId": "theravance-biopharma",
  "authorName": "Theravance Biopharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 31,
  "pageCount": 44,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "appendix_disclosure",
  "function": "front_matter",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-1317-767b-825b-77b5f795fc6c/31",
  "deckHref": "/decks/019de074-1317-767b-825b-77b5f795fc6c",
  "deckJsonHref": "/decks/019de074-1317-767b-825b-77b5f795fc6c.json",
  "deckAnchorHref": "/decks/019de074-1317-767b-825b-77b5f795fc6c#slide-31",
  "components": [
    {
      "bbox": {
        "h": 0.035,
        "w": 0.598,
        "x": 0.042,
        "y": 0.555
      },
      "kind": "list",
      "text": "The study was funded by Theravance Biopharma Ireland Limited",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66809e77-f898-4807-8b7b-a0339477bfc2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.355,
        "w": 0.916,
        "x": 0.042,
        "y": 0.175
      },
      "kind": "list",
      "text": "Dr. Roy Freeman has received personal compensation and/or stock options for serving on scientific advisory boards of AlgoRx, Applied Therapeutics, Clexio, Cutaneous NeuroDiagnostics, Glenmark, GW Pharma, Glaxo-Smith Kline, Inhibikase, Eli Lilly, Maxona, Novartis, NeuroBo, Regency, Theravance Biopharma, and Vertex; has received personal compensation for editorial activities (Editor) with Autonomic Neuroscience – Basic and Clinical; has received research support from the National Institutes of Health (1R01NS10584401A1, R01HL111465-01A1); is a member of the Multiple System Atrophy Coalition Clinical Advisory Board, and Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks; and is a Board member of the International Diabetic Neuropathy Consortium of the Peripheral Nerve Society and the Neuropathic Pain Consortium of the Peripheral Nerve Society",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c42cc63e-55c0-4861-8fb0-82c4e8a3f93e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.098,
        "w": 0.482,
        "x": 0.042,
        "y": 0.045
      },
      "kind": "title",
      "text": "Presenting Author Disclosure",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32c30ea3-e36d-46ee-b1c2-001405ea9a0b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}